BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 17612852)

  • 1. Duloxetine: review of its pharmacology, and therapeutic use in depression and other psychiatric disorders.
    Gupta S; Nihalani N; Masand P
    Ann Clin Psychiatry; 2007; 19(2):125-32. PubMed ID: 17612852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Duloxetine in the treatment of major psychiatric and neuropathic disorders.
    Müller N; Schennach R; Riedel M; Möller HJ
    Expert Rev Neurother; 2008 Apr; 8(4):527-36. PubMed ID: 18416656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy, safety and tolerability of duloxetine 60 mg once daily in major depression.
    Cowen PJ; Ogilvie AD; Gama J
    Curr Med Res Opin; 2005 Mar; 21(3):345-56. PubMed ID: 15811202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Symptoms following abrupt discontinuation of duloxetine treatment in patients with major depressive disorder.
    Perahia DG; Kajdasz DK; Desaiah D; Haddad PM
    J Affect Disord; 2005 Dec; 89(1-3):207-12. PubMed ID: 16266753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Duloxetine in the acute and continuation treatment of major depressive disorder.
    Bochsler L; Olver JS; Norman TR
    Expert Rev Neurother; 2011 Nov; 11(11):1525-39. PubMed ID: 22014130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of pain on outcomes in a trial of duloxetine treatment of major depressive disorder.
    Arnold LM; Meyers AL; Sunderajan P; Montano CB; Kass E; Trivedi M; Wohlreich MM
    Ann Clin Psychiatry; 2008; 20(4):187-93. PubMed ID: 19034749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New hope in the treatment of painful symptoms in depression.
    Briley M
    Curr Opin Investig Drugs; 2003 Jan; 4(1):42-5. PubMed ID: 12625027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of depression in the presence of pain symptoms.
    Mohr P; Bitter I; Svestka J; Seifritz E; Karamustafalioglu O; Koponen H; Sartorius N
    Psychiatr Danub; 2010 Mar; 22(1):4-13. PubMed ID: 20305585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors predicting reduced antidepressant response: experience with the SNRI duloxetine in patients with major depression.
    Howland RH; Wilson MG; Kornstein SG; Clayton AH; Trivedi MH; Wohlreich MM; Fava M
    Ann Clin Psychiatry; 2008; 20(4):209-18. PubMed ID: 19034753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of duloxetine in painful symptoms: an analgesic or antidepressant effect?
    Perahia DG; Pritchett YL; Desaiah D; Raskin J
    Int Clin Psychopharmacol; 2006 Nov; 21(6):311-7. PubMed ID: 17012978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Duloxetine for major depressive episodes in the course of psychotic disorders: an observational clinical trial.
    Englisch S; Knopf U; Scharnholz B; Kuwilsky A; Deuschle M; Zink M
    J Psychopharmacol; 2009 Nov; 23(8):875-82. PubMed ID: 18583440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preclinical discovery of duloxetine for the treatment of depression.
    Torres-Sanchez S; Perez-Caballero L; Mico JA; Elorza J; Berrocoso E
    Expert Opin Drug Discov; 2012 Aug; 7(8):745-55. PubMed ID: 22680253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is duloxetine effective treatment for depression with atypical features?
    Stewart JW; Deliyannides DA; McGrath PJ
    Int Clin Psychopharmacol; 2008 Nov; 23(6):333-6. PubMed ID: 18854721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Duloxetine treatment of major depressive episodes in the course of psychotic disorders.
    Zink M; Knopf U; Mase E; Kuwilsky A; Deuschle M
    Pharmacopsychiatry; 2006 May; 39(3):109-11. PubMed ID: 16721699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Duloxetine (Cymbalta) for diabetic neuropathic pain.
    Med Lett Drugs Ther; 2005 Aug 15-29; 47(1215-1216):67-8. PubMed ID: 16103866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effective treatment of depression. Early reduction of painful concomitant symptoms increases the probability of remission].
    Ameri AA
    MMW Fortschr Med; 2010 Nov; 152(44):78-9. PubMed ID: 21158181
    [No Abstract]   [Full Text] [Related]  

  • 17. Duloxetine hydrochloride: a new dual-acting medication for the treatment of major depressive disorder.
    Hunziker ME; Suehs BT; Bettinger TL; Crismon ML
    Clin Ther; 2005 Aug; 27(8):1126-43. PubMed ID: 16199241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Painful physical symptoms in depression: a clinical challenge.
    Wise TN; Fishbain DA; Holder-Perkins V
    Pain Med; 2007 Sep; 8 Suppl 2():S75-82. PubMed ID: 17714118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-fatal overdose of duloxetine in combination with other antidepressants and benzodiazepines.
    Menchetti M; Gozzi BF; Saracino MA; Mercolini L; Petio C; Raggi MA
    World J Biol Psychiatry; 2009; 10(4 Pt 2):385-9. PubMed ID: 18609436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patterns of depressive symptom response in duloxetine-treated outpatients with mild, moderate or more severe depression.
    Shelton RC; Prakash A; Mallinckrodt CH; Wohlreich MM; Raskin J; Robinson MJ; Detke MJ
    Int J Clin Pract; 2007 Aug; 61(8):1337-48. PubMed ID: 17627710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.